SEDAR Interim Financial Statements

[
  {
    "companyName": "Delivra Health Brands Inc.",
    "reportingPeriodEnd": "2025-12-31",
    "reportStatus": "Unaudited",
    "auditorName": null,
    "auditorKeyMatters": [],
    "balanceSheet": {
      "cash": 3229,
      "accountsReceivable": 2812,
      "inventories": 1840,
      "prepaidExpensesAndDeposits": 162,
      "totalCurrentAssets": 8043,
      "propertyPlantAndEquipment": 0,
      "totalAssets": 8043,
      "accountsPayableAndAccruedLiabilities": 1984,
      "loansPayableCurrent": 318,
      "totalCurrentLiabilities": 2302,
      "loansPayableNonCurrent": 1943,
      "totalLiabilities": 4245,
      "shareCapital": 148630,
      "otherReserves": 26187,
      "accumulatedOtherComprehensiveLoss": -165,
      "accumulatedDeficit": -170854,
      "totalEquity": 3798,
      "totalLiabilitiesAndEquity": 8043,
      "cashPerShare": 0.1033,
      "workingCapitalPerShare": 0.1837
    },
    "incomeStatement": {
      "revenue": 5640,
      "costOfSales": 3115,
      "inventoryWriteDown": 52,
      "grossProfit": 2473,
      "generalAndAdministration": 2026,
      "salesAndMarketing": 812,
      "depreciationAndAmortization": 27,
      "shareBasedCompensation": 80,
      "totalExpenses": 2945,
      "lossFromOperations": -472,
      "interestAndFinanceCosts": -146,
      "gainLossFromExtinguishmentForgivenessOfAccountsPayable": 123,
      "foreignExchangeGainLoss": -7,
      "totalOtherExpenseIncome": -30,
      "netLoss": -502,
      "foreignCurrencyTranslation": -19,
      "comprehensiveLoss": -521,
      "netLossPerShareBasicAndDiluted": -0.02,
      "weightedAverageSharesOutstanding": 31261781
    },
    "cashFlowStatement": {
      "netProfitLoss": -502,
      "depreciationAndAmortization": 27,
      "inventoryWriteDown": 52,
      "shareBasedCompensation": 80,
      "gainLossFromExtinguishmentForgivenessOfAccountsPayable": -123,
      "interestAndAccretionOnLoansAndBorrowings": 158,
      "changesInAccountsReceivable": 502,
      "changesInInventories": 853,
      "changesInPrepaidExpensesAndDeposits": 15,
      "changesInAccountsPayableAndAccruedLiabilities": -1106,
      "netCashUsedInOperatingActivities": -44,
      "repaymentOfLoansAndBorrowings": -10,
      "netCashUsedInFinancingActivities": -10,
      "effectOfForeignExchangeOnCash": -19,
      "changeInCashDuringThePeriod": -73,
      "cashBeginningOfPeriod": 3302,
      "cashEndOfPeriod": 3229
    },
    "investmentsAndOtherAssets": [],
    "shareStructure": {
      "authorizedShares": "unlimited",
      "issuedShares": 31261781,
      "classesOfShares": ["common shares"],
      "warrants": [
        {
          "number": 6000000,
          "exercisePrice": 0.5,
          "expiryDate": "2026-12-12"
        }
      ],
      "options": [
        {
          "number": 445000,
          "exercisePrice": 1.2,
          "expiryDate": "2026-04-08"
        },
        {
          "number": 410000,
          "exercisePrice": 0.5,
          "expiryDate": "2027-10-31"
        },
        {
          "number": 1335000,
          "exercisePrice": 0.5,
          "expiryDate": "2029-05-27"
        },
        {
          "number": 100000,
          "exercisePrice": 0.3,
          "expiryDate": "2028-08-06"
        }
      ],
      "rightsConvertibleInstruments": null
    },
    "managementCompensation": {
      "currency": "CAD",
      "periods": {
        "threeMonthsEndedDec312025": {
          "salariesAndBenefits": 168,
          "directorsFees": 60,
          "shareBasedCompensation": 20,
          "total": 248
        },
        "sixMonthsEndedDec312025": {
          "salariesAndBenefits": 342,
          "directorsFees": 120,
          "shareBasedCompensation": 40,
          "total": 502
        }
      },
      "namedIndividuals": [],
      "otherRelatedPartyTransactions": []
    },
    "subsequentEvents": []
  }
]